CA
QGENF

Commerzbank Aktiengesellschaft’s QIAGEN NV QGENF Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,000
Closed -$328K – 1282
2014
Q4 		$328K Sell
14,000
-4,000
-22% -$93.7K ﹤0.01% 1068
2014
Q3 		$410K Buy
+18,000
New +$410K ﹤0.01% 998
2014
Q2 		– Sell
-10,000
Closed -$211K – 1278
2014
Q1 		$211K Sell
10,000
-2,500
-20% -$52.8K ﹤0.01% 1151
2013
Q4 		$277K Sell
12,500
-44,000
-78% -$975K ﹤0.01% 1259
2013
Q3 		$1.21M Buy
56,500
+8,800
+18% +$188K 0.01% 820
2013
Q2 		$950K Buy
+47,700
New +$950K ﹤0.01% 924

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Commerzbank Aktiengesellschaft's QGENF Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 331,022 shares — an estimated $9.28M sold.

Commerzbank Aktiengesellschaft first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $31.3M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 331,022 QIAGEN NV shares in Q1 2017, an estimated $9.28M.
  • Commerzbank Aktiengesellschaft first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Commerzbank Aktiengesellschaft's QIAGEN NV position peaked at $31.3M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.